Learn more

NATREON INC

Overview
  • Total Patents
    102
  • GoodIP Patent Rank
    38,875
About

NATREON INC has a total of 102 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are BROWN SANDRA, LEGACY HEALTHCARE HOLDING LTD and EMBRO WILLIAM J.

Patent filings per year

Chart showing NATREON INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ghosal Shibnath 57
#2 Kalidindi Sanyasi R 29
#3 Sen Chandan K 18
#4 Veeraragavan Muruganandam 13
#5 Kalidindi Sanyasi 9
#6 Krishnamurthy Sairam 7
#7 Sen Chandan 2
#8 Chaudhuri Ratan 2
#9 Puccetti Germain 1
#10 Chandan K Sen 1

Latest patents

Publication Filing date Title
US2020138892A1 Anti-diabetic activity of neem extract and synergistic combinations of urolithins a and b
EP3755320A1 Synergistic combinations of urolithins a and b for improving cognitive capacity or cognitive function
AU2018408840A1 Synergistic combinations of Urolithins A and B for improving cognitive capacity or cognitive function
CA3104621A1 Improvement of blood microperfusion to skin by shilajit
US2019388322A1 Improvement of blood microperfusion to skin by shilajit
US2016074452A1 Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health
WO2016186695A1 Synergistic compositions containing chromium with phyllanthus emblica and shilajit for improving endothelial function and cardiovascular health
KR20170072236A Promoting muscle building and repair and treating disorders related to collagen and pertinent proteins by using shilajit
WO2015179675A1 Chromium-containing compositions for improving endothelial function and cardiovascular health
WO2015191206A1 Phyllanthus emblica compositions for reduction of blood glucose levels
CA2876719A1 Use of terminalia chebula extract for treatment of osteoarthritis
US2016220609A1 Regulation of steroidogenic activity by using purified shilajit
EP2898891A2 Terminalia bellerica extract for inhibition of xanthine oxidase and lowering serum uric acid
US2014356466A1 Method for treating pain and inflammation associated with arthritis using chromium-three cation in combination with phyllanthus emblica and shilajit
US2014079729A1 Method for improving endothelial function and decreasing cardiovascular morbidity using shilajit
US2013266676A1 Terminalia chebula compositions and method of extracting same
US2013261068A1 Compositions and method for improving endothelial function and cardiovascular health
US2013115316A1 Indolealkylamino-withasteroid conjugates and method of use
US2013122119A1 Phyllanthus amarus compositions and method of extracting same
EP2049136A1 Mitochondria-targeted antioxidants